AMP-Activated Protein Kinase Is Not Down-Regulated in Human Skeletal Muscle of Obese Females
The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Obesity in humans is associated with lipid accumulation in skeletal muscle, insulin and leptin resistance, and type 2 diabetes. AMP-activated protein kinase (AMPK) is an important regulator of fatty acid (FA) metabolism in skeletal muscle. To address the hypothesis that lipid accumulation in skeletal muscle of obese subjects may be due to down-regulation of AMPK, we measured mRNA and protein levels of AMPK isoforms, AMPKalpha1 and -alpha2 activity, AMPK kinase activity, acetyl-coenzyme A carboxylase (ACCbeta) expression and phosphorylation, and FA metabolism in biopsies of rectus abdominus muscle from lean and obese women. We also examined the effect of 5-aminoimidazole-4-carboxamide riboside (AICAR) on AMPK activity and the effects of AICAR and leptin on FA metabolism. Skeletal muscle of obese subjects had increased total FA uptake and triglyceride esterification, and leptin failed to stimulate FA oxidation. However, AMPK mRNA and protein expression, AMPKalpha1 and -alpha2 activities, AMPK kinase activity, ACCbeta phosphorylation, and FA oxidation were similar in lean and obese subjects. Moreover, AICAR increased AMPKalpha2 activity, ACCbeta phosphorylation, and palmitate oxidation to a similar degree in muscle from lean and obese subjects. We conclude that the abnormal lipid metabolism and leptin resistance of skeletal muscle of obese subjects is not due to down-regulation of AMPK. In addition, the similar stimulation by AICAR of AMPK in skeletal muscle of lean and obese subjects suggests that direct pharmacological activation of AMPK may be a therapeutic approach for stimulating FA oxidation in the treatment of human obesity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Thus, clinical studies have demonstrated that obese, insulin-resistant, and type 2 diabetic individuals do not exhibit a reduced capacity to oxidize fatty acids (73,74) and have normal, or even increased, mitochondrial function, as compared with lean controls (56,75).”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [74]
Citations
Cites
Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., et al. (2002) · Nature Medicine · doi:10.1038/nm788 · Cited by 4,238
Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase
Minokoshi, Y., Kim, Y.-B., Peroni, O. D., Fryer, L. G. D., Müller, C., Carling, D., & Kahn, B. B. (2002) · Nature · doi:10.1038/415339a · Cited by 2,053
Heymsfield, S. B., Greenberg, A. S., Fujioka, K., Dixon, R. M., Kushner, R., Hunt, T., Lubina, J. A., Patane, J., Self, B., Hunt, P., et al. (1999) · JAMA · doi:10.1001/jama.282.16.1568 · Cited by 1,422
Leptin-Replacement Therapy for Lipodystrophy
Oral, E. A., Simha, V., Ruiz, E., Andewelt, A., Premkumar, A., Snell, P., Wagner, A. J., DePaoli, A. M., Reitman, M. L., Taylor, S. I., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012437 · Cited by 1,247
Kelley, D. E., Goodpaster, B., Wing, R. R., & Simoneau, J.-A. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.277.6.e1130 · Cited by 1,096
Zong, H., Ren, J. M., Young, L. H., Pypaert, M., Mu, J., Birnbaum, M. J., & Shulman, G. I. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.252625599 · Cited by 1,036
Merrill, G. F., Kurth, E. J., Hardie, D. G., & Winder, W. W. (1997) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1997.273.6.e1107 · Cited by 1,025
Musi, N., Hirshman, M. F., Nygren, J., Svanfeldt, M., Bavenholm, P., Rooyackers, O., Zhou, G., Williamson, J. M., Ljunqvist, O., Efendic, S., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.7.2074 · Cited by 806
Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy
Petersen, K. F., Oral, E. A., Dufour, S., Befroy, D., Ariyan, C., Yu, C., Cline, G. W., DePaoli, A. M., Taylor, S. I., Gorden, P., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215001 · Cited by 800
Activation of AMP-activated protein kinase increases mitochondrial enzymes in skeletal muscle
Winder, W. W., Holmes, B. F., Rubink, D. S., Jensen, E. B., Chen, M., & Holloszy, J. O. (2000) · Journal of Applied Physiology · doi:10.1152/jappl.2000.88.6.2219 · Cited by 709
Cited by
Steinberg, G. R., & Kemp, B. E. (2009) · Physiological Reviews · doi:10.1152/physrev.00011.2008 · Cited by 1,637
Self-citationAdipose tissue as an endocrine organ
Galic, S., Oakhill, J. S., & Steinberg, G. R. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.08.018 · Cited by 1,562
Self-citationInsulin sensitivity: Modulation by nutrients and inflammation
Schenk, S., Saberi, M., & Olefsky, J. M. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34260 · Cited by 1,191
AMPK and the biochemistry of exercise: implications for human health and disease
Richter, E. A., & Ruderman, N. B. (2009) · Biochemical Journal · doi:10.1042/bj20082055 · Cited by 481
Steinberg, G. R., Michell, B. J., van Denderen, B. J. W., Watt, M. J., Carey, A. L., Fam, B. C., Andrikopoulos, S., Proietto, J., Görgün, C. Z., Carling, D., et al. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.11.005 · Cited by 417
Self-citationThe role of AMP‐activated protein kinase in mitochondrial biogenesis
Reznick, R. M., & Shulman, G. I. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.109512 · Cited by 373
“While rodent studies have demonstrated a potential link between excess lipid accumulation and impaired AMPK activity, human studies have not found any similar associations (Hojlund et al. 2004; Steinberg et al. 2004).”
BackgroundAMPK regulation of fatty acid metabolism and mitochondrial biogenesis: implications for obesity.
O’Neill, H. M., Holloway, G. P., & Steinberg, G. R. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.06.019 · Cited by 364
Self-citationSrivastava, R. A. K., Pinkosky, S. L., Filippov, S., Hanselman, J. C., Cramer, C. T., & Newton, R. S. (2012) · Journal of Lipid Research · doi:10.1194/jlr.r025882 · Cited by 296
“reported no differences in AMPK activities or fatty acid oxidation in a similar setting (158).”
BackgroundMolecular and cellular mechanisms linking inflammation to insulin resistance and β-cell dysfunction
Khodabandehloo, H., Gorgani-Firuzjaee, S., Panahi, G., & Meshkani, R. (2016) · Translational Research · doi:10.1016/j.trsl.2015.08.011 · Cited by 295
“For example, SOCS1 and SOCS3 expression are increased in the liver, adipose tissue [185] and muscle [186] of obese rodents.”
BackgroundAMPK and Exercise: Glucose Uptake and Insulin Sensitivity
O'Neill, H. M. (2013) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2013.37.1.1 · Cited by 295
Bandyopadhyay, G. K., Yu, J. G., Ofrecio, J., & Olefsky, J. M. (2006) · Diabetes · doi:10.2337/db06-0062 · Cited by 291
“A third study found no change in AMP kinase activity, but it compared lean and obese nondiabetic female subjects (43).”
BackgroundResultDiet-induced Obesity Alters AMP Kinase Activity in Hypothalamus and Skeletal Muscle
Martin, T. L., Alquier, T., Asakura, K., Furukawa, N., Preitner, F., & Kahn, B. B. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512831200 · Cited by 281
The adipocyte as an endocrine organ in the regulation of metabolic homeostasis
Harwood, H. J. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.12.010 · Cited by 273
“SOCS3 is also up-regulated in skeletal muscle upon high-fat feeding and is associated with leptin resistance in that tissue (Carey et al., 2006; Steinberg et al., 2004b).”
BackgroundFree fatty acids and skeletal muscle insulin resistance
Kraegen, E. W., & Cooney, G. J. (2008) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000319118.44995.9a · Cited by 206
Chen, M. B., McAinch, A. J., Macaulay, S. L., Castelli, L. A., O’Brien, P. E., Dixon, J. B., Cameron-Smith, D., Kemp, B. E., & Steinberg, G. R. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1980 · Cited by 200
“The gAD and AICAR concentrations and time points used in this study were the same as previously demonstrated to maximally activate AMPK in rodent skeletal muscle (3) and primary human muscle cells, respectively (21).”
BackgroundMethodResultInfluentialSelf-citationBai, A., Ma, A. G., Yong, M., Weiss, C. R., Ma, Y., Guan, Q., Bernstein, C. N., & Peng, Z. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.08.009 · Cited by 181
Wojtaszewski, J. F. P., Birk, J. B., Frøsig, C., Holten, M., Pilegaard, H., & Dela, F. (2005) · The Journal of Physiology · doi:10.1113/jphysiol.2005.082669 · Cited by 170
“This is in agreement with previous findings in individuals with T2DM and in insulin-resistant obese subjects (Musi et al. 2001; Højlund et al. 2004; Steinberg et al. 2004).”
ResultLin, R. C. Y., Weeks, K. L., Gao, X.-M., Williams, R. B. H., Bernardo, B. C., Kiriazis, H., Matthews, V. B., Woodcock, E. A., Bouwman, R. D., Mollica, J. P., et al. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.201988 · Cited by 170
Deletion of Skeletal Muscle SOCS3 Prevents Insulin Resistance in Obesity
Jørgensen, S. B., O’Neill, H. M., Sylow, L., Honeyman, J. E., Hewitt, K. A., Palanivel, R., Fullerton, M. D., Öberg, L., Balendran, A., Galić, S., et al. (2012) · Diabetes · doi:10.2337/db12-0443 · Cited by 162
“Consistent with this, we found that energy expenditure, activity levels, food intake, mitochondrial capacity, as well as skeletal muscle STAT3 and AMPK phosphorylation were comparable between genotypes.”
BackgroundInfluentialSelf-citationAMPK‐independent pathways regulate skeletal muscle fatty acid oxidation
Dzamko, N., Schertzer, J. D., Ryall, J. G., Steel, R., Macaulay, S. L., Wee, S., Chen, Z., Michell, B. J., Oakhill, J. S., Watt, M. J., et al. (2008) · The Journal of Physiology · doi:10.1113/jphysiol.2008.159814 · Cited by 147
“…rodents and humans the activation of AMPK by aminoimidazole-4-carboxymide-1-β-D-ribofuranoside (AICAR) (Merrill et al. 1997; Koistinen et al. 2003; Steinberg et al. 2004), or muscle contractions (Vavvas et al. 1997; Winder et al. 1997; Chen et al. 2000; Fujii et al. 2000; Wojtaszewski et al.…”
BackgroundInfluentialSelf-citationExercise-induced AMPK activity in skeletal muscle: Role in glucose uptake and insulin sensitivity
Friedrichsen, M., Mortensen, B., Pehmøller, C., Birk, J. B., & Wojtaszewski, J. F. P. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.06.013 · Cited by 143
“However, previous studies investigating the potential link between adiposity and AMPK activity have provided inconsistent data: In both rodents and humans obesity was generally not associated with reductions in AMPK protein levels in skeletal muscle (Sriwijitkamol et al., 2007; Steinberg et al., 2004; Mortensen et al.…”
Effects of cannabinoid receptors on skeletal muscle oxidative pathways
Cavuoto, P., McAinch, A. J., Hatzinikolas, G., Cameron‐Smith, D., & Wittert, G. (2006) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2006.12.038 · Cited by 149
Fuel economy in food‐deprived skeletal muscle: signaling pathways and regulatory mechanisms
de Lange, P., Moreno, M., Silvestri, E., Lombardi, A., Goglia, F., & Lanni, A. (2007) · The FASEB Journal · doi:10.1096/fj.07-8527rev · Cited by 153
“The above-mentioned studies on rats have demonstrated a link between lipid accumulation and impaired AMPK activity in skeletal muscle, whereas initially human studies (63, 64 ) have not provided evidence of any similar associations.”
ResultMitochondrial Dysfunction in Type 2 Diabetes and Obesity
Højlund, K., Mogensen, M., Sahlin, K., & Beck-Nielsen, H. (2008) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2008.06.006 · Cited by 135
Smith, A. C., Mullen, K. L., Junkin, K. A., Nickerson, J., Chabowski, A., Bonen, A., & Dyck, D. J. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00677.2006 · Cited by 139
“Previous studies have shown that AMPK content is not downregulated in obese human skeletal muscle (54) and is capable of being activated during an acute exercise bout in muscle from subjects with T2D (41), suggesting that AMPK is a possible therapeutic target in T2D.”
BackgroundSelf-citationSteinberg, G. R., McAinch, A. J., Chen, M. B., O’Brien, P. E., Dixon, J. B., Cameron-Smith, D., & Kemp, B. E. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0638 · Cited by 116
“We (19) and others (40) recently demonstrated that the mRNA and protein expression of AMPK isoforms is not altered in skeletal muscle of obese or type 2 diabetic subjects and that pharmacological activation of AMPK by AICAR is maintained (19, 31, 41).”
BackgroundSelf-citationAMP-activated protein kinase: A target for old drugs against diabetes and cancer
Russo, G. L., Russo, M., & Ungaro, P. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.05.023 · Cited by 122
AMPK-mediated regulation of transcription in skeletal muscle
McGee, S. L., & Hargreaves, M. (2010) · Clinical Science · doi:10.1042/cs20090533 · Cited by 112
Aguer, C., Mercier, J. G., Man, C. Y. W., Metz, L., Bordenave, S., Lambert, K., Jean, E., Lantier, L., Bounoua, L., Brun, J. ‐., et al. (2010) · Diabetologia · doi:10.1007/s00125-010-1708-x · Cited by 118
Boon, H., Bosselaar, M., Praet, S., Blaak, E. E., Saris, W. H. M., Wagenmakers, A. J. M., McGee, S. L., Tack, C. J., Smits, P., Hargreaves, M., et al. (2008) · Diabetologia · doi:10.1007/s00125-008-1108-7 · Cited by 109
“Ex vivo studies in human skeletal muscle tissue samples have yielded similar results, demonstrating that AICAR increases glucose transport [13] and fatty acid oxidation [ 14 ], which is accompanied by an increase in AMPK phosphorylation and/or activity [13, 14] and ACC phosphorylation [13, 14].”
InfluentialA metabolic link to skeletal muscle wasting and regeneration
Koopman, R., Ly, C. H., & Ryall, J. G. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00032 · Cited by 107
“…samples from obese and type 2 diabetes patients, AMPK expression and activation are not significantly different from controls (Hojlund et al., 2004; Steinberg et al., 2004), suggesting that changes in AMPK signaling may not be the primary defect preceding metabolic changes associated with these…”
BackgroundThe Role of AMP-Activated Protein Kinase in Obesity
Kola, B., Grossman, A. B., & Korbonits, M. (2008) · Frontiers of Hormone Research · doi:10.1159/000115366 · Cited by 100
Cuthbertson, D. J., Babraj, J., Mustard, K. J. W., Towler, M. C., Green, K. A., Wackerhage, H., Leese, G. P., Baar, K., Thomason-Hughes, M., Sutherland, C. D., et al. (2007) · Diabetes · doi:10.2337/db06-1716 · Cited by 115
“However, AMPK activity normally increases 150– 200% in response to treatments including AICAR, metformin, or exercise (21,37,39,40).”
BackgroundGalić, S., Sachithanandan, N., Kay, T. W. H., & Steinberg, G. R. (2014) · Biochemical Journal · doi:10.1042/bj20140143 · Cited by 106
Self-citationAMPK‐dependent hormonal regulation of whole‐body energy metabolism
Dzamko, N. L., & Steinberg, G. R. (2009) · Acta Physiologica · doi:10.1111/j.1748-1716.2009.01969.x · Cited by 88
“2003) or moderately obese humans (Steinberg et al. 2004) or high-fat diet-fed mice (Martin et al.”
BackgroundSelf-citationKola, B., Christ-Crain, M., Lolli, F., Arnaldi, G., Giacchetti, G., Boscaro, M., Grossman, A. B., & Korbonits, M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1297 · Cited by 85
Insulin resistance and fuel homeostasis: the role of AMP‐activated protein kinase
Hegarty, B. D., Turner, N., Cooney, G. J., & Kraegen, E. W. (2009) · Acta Physiologica · doi:10.1111/j.1748-1716.2009.01968.x · Cited by 77
“…AMPK expression, activity and activation by exercise are attenuated in obese and/or T2D patients (Bruce et al. 2005, Bandyopadhyay et al. 2006, Sriwijitkamol et al. 2007), other studies find that there is no defect (Musi et al. 2001, Hojlund 2003, Koistinen et al. 2003, Steinberg et al. 2004).”
BackgroundHøjlund, K., Birk, J. B., Klein, D. K., Levin, K., Rose, A. J., Hansen, B. F., Nielsen, J. N., Beck-Nielsen, H., & Wojtaszewski, J. F. P. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0897 · Cited by 77
Steinberg, G. R., Macaulay, S. L., Febbraio, M. A., & Kemp, B. E. (2006) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y06-005 · Cited by 77
“Supporting this idea are recent studies demonstrating that the pharmacological activation of AMPK with AICAR increases both skeletal muscle (Shearer et al. 2004; Steinberg et al. 2004) and heart (Luiken et al.”
BackgroundSelf-citationBai, A., Yong, M., Ma, A. G., Ma, Y., Weiss, C. R., Guan, Q., Bernstein, C. N., & Peng, Z. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.164954 · Cited by 72
“, 2008), in obese females for stimulating fatty acid oxidation (Steinberg et al., 2004), and in healthy men to determine whether AICAR stimulates muscle glucose uptake in humans (Cuthbertson et al.”
Backgroundvon Loeffelholz, C., Coldewey, S. M., & Birkenfeld, A. L. (2021) · Cells · doi:10.3390/cells10071822 · Cited by 73
Højlund, K., Frystyk, J., Levin, K., Flyvbjerg, A., Wojtaszewski, J. F. P., & Beck‐Nielsen, H. (2006) · Diabetologia · doi:10.1007/s00125-006-0240-5 · Cited by 72
Wijngaarden, M. A., van der Zon, G. C., van Dijk, K. W., Pijl, H., & Guigas, B. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00008.2013 · Cited by 71
Fuentes, T., Ara, I., Guadalupe‐Grau, A., Larsen, S., Stallknecht, B., Olmedillas, H., Santana, A., Helge, J. W., Calbet, J. A. L., & Guerra, B. (2010) · Experimental Physiology · doi:10.1113/expphysiol.2009.049270 · Cited by 62
“Another study found no differences between obese and control women in AMPK activity and Ser221ACCβ phosphorylation in the rectus abdominis muscle (Steinberg et al. 2004a).”
BackgroundChronic rosiglitazone treatment restores AMPKα2 activity in insulin-resistant rat skeletal muscle
Lessard, S. J., Chen, Z.-P., Watt, M. J., Hashem, M., Reid, J. J., Febbraio, M. A., Kemp, B. E., & Hawley, J. A. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00096.2005 · Cited by 60
Self-citationThe interaction between adipokines, diet and exercise on muscle insulin sensitivity
Stefanyk, L. E., & Dyck, D. J. (2010) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e328338236e · Cited by 57
Self-citationTanaka, T., Hidaka, S., Masuzaki, H., Yasue, S., Minokoshi, Y., Ebihara, K., Chusho, H., Ogawa, Y., Toyoda, T., Sato, K., et al. (2005) · Diabetes · doi:10.2337/diabetes.54.8.2365 · Cited by 64
“Very recently, a study (43) using human rectus abdominis muscle has demonstrated that in muscle from obese subjects, fatty acid esterification is augmented, while AMPK activity is not downregulated.”
BackgroundTaylor, E. B., Ellingson, W. J., Lamb, J. D., Chesser, D. G., & Winder, W. W. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00516.2004 · Cited by 63
“A recent study found that human skeletal muscle AMPK signaling is not impaired with obesity although P-AMPK was not measured directly (50).”
BackgroundMethodCytokine Regulation of AMPK signalling
Steinberg, G. (2009) · Frontiers in Bioscience · doi:10.2741/3350 · Cited by 50
“Despite the pronounced effects of leptin in models of leptin deficiency (53) or lipodystrophy (70), rodents fed a high-fat diet are resistant to the effects of leptin (71) and recombinant leptin infusion has minimal effects on body mass and food intake under these conditions (72) Skeletal muscle leptin resistance deve…”
BackgroundSelf-citationBrandt, N., Bock, K. D., Richter, E. A., & Hespel, P. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00098.2010 · Cited by 59
Steinberg, G. R., Watt, M. J., Ernst, M., Birnbaum, M. J., Kemp, B. E., & Jørgensen, S. B. (2009) · Diabetes · doi:10.2337/db08-0659 · Cited by 49
Self-citationWedellová, Z., DIETRICH, J., Šiklová, M., Kološtová, K., Kováčiková, M., Dušková, M., Brož, J., Vedral, T., Štich, V., & Polak, J. (2011) · Physiological Research · doi:10.33549/physiolres.931863 · Cited by 51
“This observation is in agreement with previously published findings in skeletal muscle (Steinberg et al. 2004, Hojlund et al. 2004), and suggests that potentially insufficient suppression of lipolysis by adiponectin in obese individuals might be due to defect localized upstream of AMPK.”
ResultSocs1 Deficiency Enhances Hepatic Insulin Signaling
Jamieson, E. L., Chong, M. M. W., Steinberg, G. R., Jovanovska, V., Fam, B. C., Bullen, D. V. R., Chen, Y., Kemp, B. E., Proietto, J., Kay, T. W. H., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502163200 · Cited by 52
Self-citationBeck Jørgensen, S., O’Neill, H. M., Hewitt, K., Kemp, B. E., & Steinberg, G. R. (2009) · Diabetologia · doi:10.1007/s00125-009-1483-8 · Cited by 42
“Moreover, in agreement with findings in ex vivo incubated muscle strips from insulin-resistant humans [27, 28], AICARstimulated αAMPK-phosphorylation and glucose uptake were normal in muscles from high-fat fed mice.”
Self-citationSimão, A. L., Afonso, M. B., Rodrigues, P. M., Gama‐Carvalho, M., Machado, M. V., Cortez‐Pinto, H., Rodrigues, C. M. P., & Castro, R. E. (2019) · Journal of Molecular Medicine · doi:10.1007/s00109-019-01796-8 · Cited by 38
“studies have found no abnormalities on the AMPK pathway in human obesity [37, 38], which is in line with our results showing almost lack of AMPK inhibition in the obesogenic”
ResultSteinberg, G. R. (2009) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h09-009 · Cited by 44
“2005), or aminoimidazole carboxamide ribonucleotide (AICAR) (Shearer et al. 2004; Steinberg et al. 2004) increases muscle fatty acid uptake.”
BackgroundSelf-citationMüssig, K., Staiger, H., Kantartzis, K., Fritsche, A., Kanz, L., & Häring, H. (2010) · Diabetic Medicine · doi:10.1111/j.1464-5491.2010.03132.x · Cited by 39
Genetic and metabolic effects on skeletal muscle AMPK in young and older twins
Mortensen, B., Poulsen, P., Wegner, L., Stender-Petersen, K. L., Ribel-Madsen, R., Friedrichsen, M., Birk, J. B., Vaag, A., & Wojtaszewski, J. F. P. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00058.2009 · Cited by 36
“Accordingly, some studies have found similar 1 and 2 expression in skeletal muscle of obese and lean subjects (8, 40).”
BackgroundHolmes, R. M., Yi, Z., Filippis, E. D., Berria, R., Shahani, S., Sathyanarayana, P., Sherman, V., Fujiwara, K., Meyer, C., Christ-Roberts, C. Y., et al. (2011) · Diabetologia · doi:10.1007/s00125-011-2173-x · Cited by 39
“Some [ 24 ], but not all [25], studies suggest that AMPK protein levels and mRNA expression are not altered in skeletal muscle of obese or type 2 diabetic patients.”
Diet-induced obese rats exhibit impaired LKB1–AMPK signaling in hypothalamus and adipose tissue
Fei-Wang, Tian, D., Tso, P., & Han, J. (2012) · Peptides · doi:10.1016/j.peptides.2012.02.003 · Cited by 28
Alkhateeb, H. H., Al‐Duais, M., & Qnais, E. Y. (2018) · Phytotherapy Research · doi:10.1002/ptr.6012 · Cited by 25
“Many studies have demonstrated that the AMPK signaling system is not disturbed in insulin‐resistance states; therefore, it has been proposed that AMPK activation may be a fruitful approach to rescue insulin resistance and to prevent type 2 diabetes progression (Steinberg et al., 2004; Steinberg & Kemp, 2009).”
BackgroundAlkhateeb, H. H., & Qnais, E. Y. (2017) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-017-0594-9 · Cited by 25
Xu, J., Chen, L., Tang, L., Chang, L., Liu, S., Tan, J., Chen, Y., Ren, Y., Liang, F., & Cui, J. (2015) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-015-0667-7 · Cited by 23
Pellatt, L. J., Rice, S., & Mason, H. D. (2011) · Endocrinology · doi:10.1210/en.2009-1429 · Cited by 26
Sopariwala, D. H., Rios, A. S., Park, M. K., Song, M. S., Kumar, A., & Narkar, V. A. (2022) · FASEB BioAdvances · doi:10.1096/fba.2022-00015 · Cited by 21
GPR119 regulates genetic markers of fatty acid oxidation in cultured skeletal muscle myotubes
Cornall, L. M., Mathai, M. L., Hryciw, D. H., Simcocks, A. C., O’Brien, P. E., Wentworth, J. M., & McAinch, A. J. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.10.003 · Cited by 23
Reciprocity Between Skeletal Muscle AMPK Deletion and Insulin Action in Diet-Induced Obese Mice
Admin, A., Lantier, L., Williams, I. M., Williams, I. M., Guérin, A., Bracy, D. P., Goelzer, M., Foretz, M., Viollet, B., Hughey, C. C., et al. (2020) · Diabetes · doi:10.2337/db19-1074 · Cited by 21
“Despite these deficits, SkM energy state is maintained (1).”
BackgroundMethodKotnik, P., Fischer‐Posovszky, P., & Wabitsch, M. (2015) · Slovenian Journal of Public Health · doi:10.1515/sjph-2015-0020 · Cited by 27
“Peripheral leptin resistance (particularly in skeletal muscle) is also linked to insulin resistance (IR) in obesity (13, 14), and to the development of nonalcoholic fatty liver disease and metabolic syndrome in children (15, 16).”
BackgroundAllerton, T. D., & Primeaux, S. D. (2015) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2015-0141 · Cited by 17
“2014); however, other studies assessing AMPK levels in obese and insulin-resistant models didnot indicate differences (Bujak et al. 2014; Lee-Younget al. 2011; Mortensen et al. 2009; Sriwijitkamol et al. 2007; Steinberg and Jorgensen 2007; Steinberg et al. 2004).”
AMP-activated protein kinase and muscle insulin resistance
Edward, W. K. (2009) · Frontiers in bioscience · doi:10.2741/3558 · Cited by 16
Central infusion of leptin does not increase AMPK signaling in skeletal muscle of sheep
Laker, R. C., Henry, B. A., Wadley, G. D., Clarke, I. J., Canny, B. J., & McConell, G. K. (2010) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00079.2010 · Cited by 14
Multiple AMPK activators inhibit l -carnitine uptake in C2C12 skeletal muscle myotubes
Shaw, A., Jeromson, S., Watterson, K. R., Pediani, J. D., Gallagher, I. J., Whalley, T., Dreczkowski, G., Brooks, N. E., Galloway, S. D. R., & Hamilton, D. L. (2017) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00026.2016 · Cited by 13
“The pharmacological activation of AMPK via the AMP mimetic AICAR has previously been shown to drive substrate uptake including glucose and fatty acids (3, 4, 43, 47).”
MethodPathways Involved In Lipid-Induced Insulin Resistance In Obesity
Watt, M. J., & Steinberg, G. R. (2007) · Future Lipidology · doi:10.2217/17460875.2.6.659 · Cited by 10
“This occurs independently from the increased FA availability and subsequent substrate flux because these responses are maintained ex vivo, where FA levels are tightly controlled [6,8].”
BackgroundSelf-citationIliuta, I.-A., Song, X., Pickel, L., Haghighi, A., Retnakaran, R. R., Scholey, J. W., Sung, H., Steinberg, G. R., & Pei, Y. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.962933 · Cited by 14
“On the other hand, AMPK activity is not always altered in the tissues of animals with HFD-induced obesity, nor is it altered in the skeletal muscle of obese humans (Steinberg et al., 2004; Bandyopadhyay et al., 2006; Martin et al., 2006).”
BackgroundSelf-citationLeptin‐like immunoreactivity in the muscle of juvenile sea bass (Dicentrarchus labrax)
Gambardella, C., Ferrando, S., Gallus, L., Ravera, S., Bianchini, P., Ramoino, P., Fasulo, S., & Tagliafierro, G. (2010) · Microscopy Research and Technique · doi:10.1002/jemt.20822 · Cited by 7
“Numerous studies tested the presence of leptin in mammalian skeletal muscle (Bjorbaek and Kahn, 2004; Dulloo et al., 2002; Maroni et al., 2003; Steinberg and Dyck, 2000; Steinberg et al., 2004; Wang et al., 1998); however, to date, no data are available about its presence in fish muscle.”
BackgroundZani, S. C. D. C., Berg, E. V., Jiang, X., Knox, A., Ackroyd, E., Getachew, A., Wu, J., & Chan, C. B. (2023) · Journal of Functional Foods · doi:10.1016/j.jff.2023.105976 · Cited by 6
Lee, M. Y., & Kim, J. H. (2011) · 대한지역사회영양학회지 · doi:10.5720/kjcn.2011.16.1.126 · Cited by 5
Barquissau, V., & Morio, B. (2011) · Nutrition Clinique et Métabolisme · doi:10.1016/j.nupar.2011.07.003 · Cited by 10
A Review on Metabolic Paradoxes and their Impact on Metabolism.
Gasmi, A., Piscopo, S., Menzel, A., & Noor, S. (2022) · PubMed · doi:10.22092/ari.2021.356277.1815 · Cited by 3
Kim, Y.-H., Park, J. H., Kwak, J.-Y., Park, J., & Ahn, T. W. (2016) · Journal of Sasang Constitutional Medicine · doi:10.7730/jscm.2016.28.2.147 · Cited by 1
Interplay between Oncogenes and Tumor Suppressor Genes in Human Disease
Parsons, S. J., DaSilva, J. O., & Parsons, J. T. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-394447-4.30056-6 · Cited by 2
Nucleotide regulation of AMP-activated protein kinase
Underwood, E. (2013) · UCL Discovery (University College London) · Cited by 1
Regulation of human adipose tissue gene expression in relation to obesity and insulin resistance
Klimčáková, E. (2007) · OpenGrey (Institut de l'Information Scientifique et Technique)
On the importance of fat cell size, location and signaling in insulin resistance
Franck, N. (2009) · DiVA (Digitala Vetenskapliga Arkivet)
Running Title: AICAR stimulation of human glucose uptake
Cuthbertson, D. J., Babraj, J., Towler, M. C., Wackerhage, H., Leese, G. P., Baar, K., Thomason-Hughes, M., Sutherland, C. D., Hardie, D. G., & Rennie, M. J. (2007)
Endocannabinoids and skeletal muscle glucose uptake.
Cavuoto, P. (2010) · Adelaide Research & Scholarship (AR&S) (University of Adelaide) · Cited by 1
Weber, T. M. (2013) · The Scholarship East Carolina University's Institutional Repository (East Carolina University)
Myocyte Androgen Receptor Modulates Body Composition and Metabolic Parameters
Fernando, S. M. (2010) · TSpace (University of Toronto)
The Immediate and Extended Effect of Diet and Exercise on Metabolic Flexibility
Allerton, T. D. (2017) · Louisiana State University · doi:10.31390/gradschool_dissertations.4493
AMP-activated protein kinase regulation of myeloid antigen presenting cell activity.
Carroll, K. (2013) · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · doi:10.18297/etd/215
“Alternatively, in a few studies of human obesity, AMPK expression and activity are not significantly decreased [74, 75].”
BackgroundThe effect of metformin-induced AMPK activation on adipogenesis and HIV replication
Alexandre, K. B. (2008) · University of the Witwatersrand, Johannesburg Institutional Repository on DSpace (University of the Witwatersrand, Johannesburg)
Inflammation intestinale et diabète de type 2 : effet du Resveratrol
Dao, T. M. A. (2011) · theses.fr (ABES) · doi:10.70675/ba3c8576z889ez4199zb7d6z98de312b9efb
Rôle et régulation de la protéine kinase AMPK au niveau intestinal
Harmel, É. (2012) · theses.fr (ABES) · doi:10.70675/0223f181zd1b3z4a87zadd0zd62495c76b6c
The AMPK signaling pathway in cell metabolism and human diseases
Zhang, Z., Gu, Y., He, H., Qiao, S., Shao, Y., 龙先铭, Huang, J., Zhang, L., & Zhou, F. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02790-6
Metadata
- Authors
- Steinberg, G. R., Smith, A. C., van Denderen, B. J. W., Chen, Z., Murthy, S., Campbell, D. J., Heigenhauser, G. J. F., Dyck, D. J., & Kemp, B. E.
- Affiliations
- The University of Melbourne (AU)
- University of Guelph (CA)
- McMaster University (CA)
- Corresponding author
- Steinberg, Gregory R.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2004-09
- Volume
- 89
- Issue
- 9
- Pages
- 4575-4580
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2126508308
- Cited by
- 97
- References
- 35
- Citations by year
- 2026: 1 · 2023: 1 · 2022: 3 · 2021: 3 · 2020: 1 · 2019: 1 · 2018: 1 · 2017: 3 · 2016: 1 · 2015: 5 · 2014: 2 · 2013: 6 · 2012: 8
- FWCI
- 2.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- AMPK, skeletal muscle, obesity, fatty acid oxidation, fatty acid metabolism, leptin resistance, acetyl-CoA carboxylase, AICAR, triglyceride esterification, rectus abdominis, type 2 diabetes, insulin resistance, lipid accumulation
- MeSH terms
- AMP-Activated Protein Kinase Kinases, Acetyl-CoA Carboxylase, Adenylate Kinase, Adult, Aminoimidazole Carboxamide, Fatty Acids, Female, Humans, Middle Aged, Obesity, Phosphorylation, Protein Kinases, Ribonucleotides, RNA, Messenger, Down-Regulation, Muscle, Skeletal, Leptin, Protein Subunits
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.